Evidence map›Paper›PMID 40588648›Full record

ArticleDrug safety2025

Characteristics of Drug-RElated Hospitalizations for Nursing HOme Residents: Cross-Sectional RENHO Study.

Alice Lopez, Chiara Alfarano, Marianne Lepetit, Leila Chebane, Nassima Redjimi, Anaïs Couret, Didier Fabre, Virginie Gardette, Driss Berdaï, Maryse Lapeyre-Mestre and 1 more

Abstract read
In one paragraph

Article in Drug safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alice Lopez *Department of Medical and Clinical Pharmacology, Regional Pharmacovigilance Centre of Toulouse, Toulouse University Hospital, Toulouse, France.
Chiara Alfarano *Department of Medical and Clinical Pharmacology, Regional Pharmacovigilance Centre of Toulouse, Toulouse University Hospital, Toulouse, France.
Marianne LepetitDepartment of Medical and Clinical Pharmacology, Methological and Statistical Supporting Center MeDataS, Regional Pharmacovigilance Centre of Toulouse, Clinical Investigation Centre 1436, Toulouse University Hospital, Toulouse, France.
Leila ChebaneDepartment of Medical and Clinical Pharmacology, Regional Pharmacovigilance Centre of Toulouse, Toulouse University Hospital, Toulouse, France.
Nassima RedjimiDepartment of Medical and Clinical Pharmacology, Regional Pharmacovigilance Centre of Toulouse, Toulouse University Hospital, Toulouse, France.
Anaïs CouretDepartment of Medical and Clinical Pharmacology, Methological and Statistical Supporting Center MeDataS, Regional Pharmacovigilance Centre of Toulouse, Clinical Investigation Centre 1436, Toulouse University Hospital, Toulouse, France.
Didier FabreDepartment of Medical Information, Toulouse University Hospital (CHU Toulouse), Toulouse, France.
Virginie GardetteDepartment of Medical and Clinical Pharmacology, Methological and Statistical Supporting Center MeDataS, Regional Pharmacovigilance Centre of Toulouse, Clinical Investigation Centre 1436, Toulouse University Hospital, Toulouse, France.
Driss BerdaïDepartment of Medical Pharmacology, Bordeaux University Hospital, Bordeaux, France.
Maryse Lapeyre-MestreDepartment of Medical and Clinical Pharmacology, Methological and Statistical Supporting Center MeDataS, Regional Pharmacovigilance Centre of Toulouse, Clinical Investigation Centre 1436, Toulouse University Hospital, Toulouse, France.
Haleh BagheriDepartment of Medical and Clinical Pharmacology, Methological and Statistical Supporting Center MeDataS, Regional Pharmacovigilance Centre of Toulouse, Clinical Investigation Centre 1436, Toulouse University Hospital, Toulouse, France. haleh.bagheri@univ-tlse3.fr.ORCID http://orcid.org/0000-0001-9585-9341

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNursing home residents with advancing age are often exposed to polypharmacy, a well-known risk factor for adverse drug reactions (ADRs), which increases the risk of hospitalization. Therefore, we assessed the characteristics of and factors associated with ADR-related emergency department (ED) admissions among nursing home residents.

methodsWe carried out a cross-sectional study using the Toulouse University Hospital discharge database to identify nursing home residents ED admissions from 1 April, 2019 to 31 March, 2020. Information was updated for 2 years after inclusion (re-admissions). Emergency department medical files were analyzed to identify factors associated with these admissions (including demographics, functional dependency level, comorbidities, body mass index, ED admission in the previous 12 previous months, and number of drugs).

resultsWe identified 1514 patients (corresponding to 2024 ED admissions), 409 of whom (27.0%) were admitted at least once for an ADR. Thirty-six nursing home residents were re-admitted in 2020 and/or 2021 for ADRs, half of whom were for the same ADR. The most frequent ADRs were falls (114, 24.3%), hemorrhagic events (106, 22.6%), and constipation (47, 10.0%) involving benzodiazepines and Z-drugs (170, 16.0%), antidepressants (125, 11.9%), antithrombotic drugs (110, 10.3%), and opioids (82, 7.7%). About 12% of ADRs were assessed as avoidable. Factors significantly associated with ADR-related ED admissions were the number of drugs (odds ratio 1.09; 95% confidence interval 1.05-1.13), previous ED admissions (odds ratio 3.47; 95% confidence interval 2.46-4.90), and overweight (odds ratio 1.54; confidence interval 1.15-2.06).

conclusionsDrug-induced iatrogenic disease could lead to ED admission for nursing home residents in approximately one-quarter of cases, 12% of which were assessed as avoidable. A previous history of ED admission and polypharmacy remain key associated factors. The awareness-raising campaigns for health professionals should be strengthened to prevent avoidable drug-induced ADRs.

Indexed as

Drug-Related Side Effects and Adverse ReactionsEmergency Service, HospitalHospitalizationNursing HomesAgedAged, 80 and overCross-Sectional StudiesFemaleHumansMaleMiddle AgedPolypharmacyRisk Factors

Identifiers

PMID40588648
PMCPMC12334531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.